Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.31 - $0.55 $82 - $146
267 Added 19.07%
1,667 $0
Q4 2022

Feb 14, 2023

SELL
$0.35 - $20.75 $0 - $20
-1 Reduced 0.07%
1,400 $0
Q3 2022

Nov 14, 2022

SELL
$0.83 - $21.25 $829 - $21,228
-999 Reduced 41.63%
1,401 $1,000
Q2 2022

Oct 27, 2022

SELL
$1.12 - $2.18 $1,367 - $2,661
-1,221 Reduced 33.72%
2,400 $3,000
Q2 2022

Aug 15, 2022

SELL
$1.12 - $2.18 $1,367 - $2,661
-1,221 Reduced 33.72%
2,400 $3,000
Q1 2022

Oct 27, 2022

BUY
$1.63 - $3.63 $1,990 - $4,432
1,221 Added 50.88%
3,621 $9,000
Q1 2022

May 13, 2022

BUY
$1.63 - $3.63 $1,988 - $4,428
1,220 Added 50.81%
3,621 $9,000
Q4 2021

Feb 14, 2022

SELL
$2.25 - $4.11 $290 - $530
-129 Reduced 5.1%
2,401 $5,000
Q3 2021

Nov 15, 2021

BUY
$2.71 - $5.9 $6,856 - $14,927
2,530 New
2,530 $10,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.